Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-09

Clinical Trial Update: The Effects of Sevelamer Carbonate on Diabetic Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sevelamer carbonate for diabetic nephropathy has been completed, with no results detailed in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renvela (sevelamer carbonate)

Snippet

Sponsor: Gary Striker | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED